scispace - formally typeset
Open AccessJournal ArticleDOI

Breast cancer as a systemic disease: a view of metastasis

Reads0
Chats0
TLDR
Results from studies in animal models suggest that specific subtypes of breast cancer may direct metastasis through recruitment and activation of haematopoietic cells, and data implicating breast cancer as a systemic disease is focused on.
Abstract
Breast cancer is now the most frequently diagnosed cancer and leading cause of cancer death in women worldwide. Strategies targeting the primary tumour have markedly improved, but systemic treatments to prevent metastasis are less effective; metastatic disease remains the underlying cause of death in the majority of patients with breast cancer who succumb to their disease. The long latency period between initial treatment and eventual recurrence in some patients suggests that a tumour may both alter and respond to the host systemic environment to facilitate and sustain disease progression. Results from studies in animal models suggest that specific subtypes of breast cancer may direct metastasis through recruitment and activation of haematopoietic cells. In this review, we focus on data implicating breast cancer as a systemic disease.

read more

Citations
More filters
Journal ArticleDOI

Tristetraprolin: A novel target of diallyl disulfide that inhibits the progression of breast cancer.

TL;DR: Knocking down TTP expression using small interfering RNA reversed the aforementioned effects of DADS, which suggests TTP is a key target of D ADS in inhibiting the progression of breast cancer.
Journal ArticleDOI

Expression and potential prognostic value of histone family gene signature in breast cancer.

TL;DR: Higher expression of histone gene sets was associated with poor overall survival, relapse- free survival and distant metastasis-free survival of BC patients, indicating that histone family genes sets may be used as prognostic factors for survival prediction for BC patients.
Journal ArticleDOI

Sorafenib Inhibits Proliferation, Migration and Invasion of Breast Cancer Cells.

TL;DR: Sorafenib has anti-cancer activity against breast cancer cells and could improve the survival of breast cancer patients by inhibiting their invasive and metastatic properties.
Journal ArticleDOI

Breast cancer metastasis in the stomach: when the gastrectomy is indicated ?

TL;DR: In this paper, the authors analyzed 12 patients with secondary gastric tumors and found that the primary tumor was breast cancer, and the metastases were found to be breast cancer and showed positivity for CK7 antibody in 83.34%, estrogen receptor in 91.67% and AE1AE3 antibody in 75%, considering all 12 cases.
Journal ArticleDOI

A prognostic 10-lncRNA expression signature for predicting the risk of tumour recurrence in breast cancer patients

TL;DR: A 10‐lncRNA signature‐based risk score was developed which was used to separate patients into high‐risk and low‐risk groups and effectively grouped patients at low and high risk of disease recurrence.
References
More filters
Journal ArticleDOI

Global cancer statistics

TL;DR: A substantial proportion of the worldwide burden of cancer could be prevented through the application of existing cancer control knowledge and by implementing programs for tobacco control, vaccination, and early detection and treatment, as well as public health campaigns promoting physical activity and a healthier dietary intake.
Journal ArticleDOI

Molecular portraits of human breast tumours

TL;DR: Variation in gene expression patterns in a set of 65 surgical specimens of human breast tumours from 42 different individuals were characterized using complementary DNA microarrays representing 8,102 human genes, providing a distinctive molecular portrait of each tumour.
Journal ArticleDOI

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

TL;DR: Survival analyses on a subcohort of patients with locally advanced breast cancer uniformly treated in a prospective study showed significantly different outcomes for the patients belonging to the various groups, including a poor prognosis for the basal-like subtype and a significant difference in outcome for the two estrogen receptor-positive groups.
Journal ArticleDOI

Fibroblasts in cancer

TL;DR: Fibroblasts are a key determinant in the malignant progression of cancer and represent an important target for cancer therapies.
Journal ArticleDOI

Complex networks orchestrate epithelial–mesenchymal transitions

TL;DR: Understanding how mesenchymal cells arise from an epithelial default status will also have a strong impact in unravelling the mechanisms that control fibrosis and cancer progression.
Related Papers (5)
Trending Questions (1)
Is metastasis the leading cause of death in breast cancer?

Yes, metastatic disease remains the underlying cause of death in the majority of patients with breast cancer who succumb to their disease.